Amgen 8-K
Leadership change
David Reese’s retirement brings Sean Bruich into the CTO role and redistributes duties to further integrate science, technology and data.
Filed 2026-04-22 16:03 ET
- 5.02 Officer/director change
- 9.01 Financial Statements and Exhibits
Summary
Amgen leadership transition and organizational changes. David M. Reese will retire as executive vice president and chief technology officer on 6/30/2026. Effective 6/1/2026, Sean Bruich will become senior vice president and chief technology officer; Reese’s responsibilities will also be redistributed among James E. Bradner (executive vice president, Research and Development, Artificial Intelligence and Data), Murdo Gordon (executive vice president, Amgen Global Markets and Policy), and Peter H. Griffith (executive vice president and CFO). Paul Burton will continue as senior vice president and chief medical officer. Amgen says the changes further integrate science, technology and data.
The summary is written by an AI model reading the filing.
Model 005 · prompt 01d34d48e3